Zhenhong Jiang

Dr. Zhenhong Jiang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2021 in Frontiers in Genetics
Verified
Journal Article
Open access
ZTZhaochong Tan
Zhaochong Tan
LWLimeng Wu
Limeng Wu
YFYan Fang
Yan Fang
PCPingshan Chen
Pingshan Chen
RWRong Wan
Rong Wan
KHKui Hong
Kui Hong
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease and mitochondria plays a key role in the progression in HCM. Here, we analyzed the expression pattern of nuclear-encoded mitochondrial genes (NMGenes) in HCM and found that the expression of NMGenes was significantly changed. A total of 316 differentially expressed NMGenes (DE-NMGenes) were identified. Pathway enrichment analyses showed that energy metabolism-related pathways such as “pyruvate metabolism” and “fatty acid degradation” were dysregulated, which highlighted the importance of energy metabolism in HCM. Next, we constructed a protein-protein interaction network based on 316 DE-NMGenes and identified thirteen hubs. Then, a total of 17 TFs (transcription factors) were predicted to potentially regulate the expression of 316 DE-NMGenes according to iRegulon, among which 8 TFs were already found involved in pathological hypertrophy. The remaining TFs (like GATA1, GATA5, and NFYA) were good candidates for further experimental verification. Finally, a mouse model of transverse aortic constriction (TAC) was established to validate the genes and results showed that DDIT4, TKT, CLIC1, DDOST, and SNCA were all upregulated in TAC mice. The present study represents the first effort to evaluate the global expression pattern of NMGenes in HCM and provides innovative insight into the molecular mechanism of HCM.

22 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
HXHuanhua XU
Huanhua XU
LYLiang Yang
Liang Yang
MTMing-Xia Tang
Ming-Xia Tang
AYAn-Ping Ye
An-Ping Ye
BTBo-Dan Tu
Bo-Dan Tu
JYJian-Feng Yi
Jian-Feng Yi
Lobeline is an alkaloid derived from the leaves of an Indian tobacco plant (Lobelia inflata), which has been prepared by chemical synthesis. It is classified as a partial nicotinic agonist and has a long history of therapeutic usage ranging from emetic and respiratory stimulant to tobacco smoking cessation agent. The presence of both cis and trans isomers in lobeline is well known, and many studies on the relationship between the structure and pharmacological activity of lobeline and its analogs have been reported. However, it is a remarkable fact that no studies have reported the differences in pharmacological activities between the two isomers. In this article, we found that different degrees of isomerization of lobeline injection have significant differences in respiratory excitatory effects in pentobarbital sodium anesthetized rats. Compared with cis-lobeline injections, the respiratory excitatory effect was significantly reduced by 50.2% after administration of injections which contained 36.9% trans-lobeline. The study on the influencing factors of isomerization between two isomers shown that this isomerization was a one-way isomerism and only converted from cis to trans, where temperature was the catalytic factor and pH was the key factor. This study reports a new discovery. Despite the widespread use of ventilators, first-aid medicines such as nikethamide and lobeline has retired to second line, but as a nonselective antagonist with high affinity for a4b2 and a3b2 nicotinic acetylcholine receptors (nAChRs). In recent years, lobeline has shown great promise as a therapeutic drug for mental addiction and nervous system disorders, such as depression, Alzheimer disease and Parkinson disease. Therefore, we suggest that the differences between two isomers should be concerned in subsequent research papers and applications.

1 January 2021 in Stem Cells and Development
Verified
Journal Article
Closed access
HXHuanhua XU
Huanhua XU
NWNing-Ning Wang
Ning-Ning Wang
ZJZhenhong Jiang
Zhenhong Jiang
YSYu-Ting Sun
Yu-Ting Sun
LXLonglong Xu
Longlong Xu
YGYue Gao
Yue Gao
A transgenic Acute Promyelocytic Leukemia (APL) murine model established by Michael Bishop by cloning a human PML-RARα cDNA into the hMRP8 expression cassette has been widely used in the all-trans retinoid acid and arsenic preparations for the research of APL. However, in the existing literature, the data of regularity and characteristics of the pathogenesis of this model were still missing which hinders the development of many studies, especially application of new technologies such as single-cell sequencing. Therefore, in this manuscript, we have made up this part of the missing data by using an improved APL murine model. We clarified the effects of different inoculation doses on the onset time, latency, morbidity, lifespan, and proportion of APL cells in peripheral blood, spleen, and bone marrow, etc. The relationship between the proportion of APL cells in the BM, spleen, and PB, and organ histological changes was also revealed. These results were a supplement and refinement of this APL model. It would add to the knowledge base of the field and aid in ensuring that accurate models are employed for directed interventions. It also provide a great convenience for the researchers who will carry out similar research.

14 December 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
HXHuanhua XU
Huanhua XU
ZJZhenhong Jiang
Zhenhong Jiang
YSYu-Ting Sun
Yu-Ting Sun
LQLi-Zhen Qiu
Li-Zhen Qiu
LXLonglong Xu
Longlong Xu
YGYue Gao
Yue Gao
Ophiopogonin D (OPD) and Ophiopogonin D (OPD) are two bioactive ingredients in Ophiopogon japonicus. Previously published studies have often focused on the therapeutic effects related to OPD’s antioxidant capacity but underestimated the cytotoxicity-related side effects of OPD, which may result in unpredictable risks. In this study, we reported another side effect of OPD, hemolysis, and what was unexpected was that this side effect also appeared with OPD. Although hemolysis effects for saponins are familiar to researchers, the hemolytic behavior of OPD or OPD and the interactions between these two isomers are unique. Therefore, we investigated the effects of OPD and OPD alone or in combination on the hemolytic behavior in vitro and in vivo and adopted chemical compatibility and proteomics methods to explain the potential mechanism. Meanwhile, to explain the drug-drug interactions (DDIs), molecular modeling was applied to explore the possible common targets. In this study, we reported that OPD caused hemolysis both in vitro and in vivo, while OPD only caused hemolysis in vivo. We clarified the differences and DDIs in the hemolytic behavior of the two isomers. An analysis of the underlying mechanism governing this phenomenon showed that hemolysis caused by OPD or OPD was related to the destruction of the redox balance of erythrocytes. In vivo, in addition to the redox imbalance, the proteomics data demonstrated that lipid metabolic disorders and mitochondrial energy metabolism are extensively involved by hemolysis. We provided a comprehensive description of the hemolysis of two isomers in Ophiopogon japonicus, and risk warnings related to hemolysis were presented. Our research also provided a positive reference for the development and further research of such bioactive components.